Champions Oncology Inc Stock
Price
Target price
€5.55
€5.55
7.770%
0.4
7.770%
-
15.12.25 / Frankfurt
WKN: A14X6S / Name: Champions / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc dominated the market today, gaining €0.40 (7.770%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 7.770% | 3.000% | -10.435% | 8.193% | 8.193% | -17.600% | -45.213% |
| Ardelyx Inc. | 1.100% | 4.231% | 4.603% | 5.906% | 6.183% | 185.065% | -8.694% |
| Krystal Biotech | -0.970% | 2.833% | 17.993% | 32.628% | 35.940% | 191.408% | - |
| Evolus Inc | 0.860% | 1.754% | -5.691% | -45.794% | -44.762% | -10.769% | 86.435% |
News
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill
Keep an Eye on These 3 Dividend Champion Stocks in 2025
A streak lasting decades is noteworthy. Whether it's a silver wedding anniversary, a quarter century of work, or The Simpsons' 37-year run, these show stability and success.
You can find examples in
7 Best Dividend Champions to Buy Now
Dividend Champions are long-term winners. These companies have grown their dividends for at least 25 straight years. They don't have to be members of the S&P 500 (SNPINDEX: ^GSPC), which broadens